Press Release-GE Healthcare Life Sciences allies with Pharmadule Morimatsu to expand KUBio

Published Thursday, November 21, 2019

Press Release - Uppsala Sweden

The KUBio "factory in a box" is expanding to accelerate the accessibility of biotherapeutics on a global scale. Additional modular platforms will be introduced in 2020 allowing biopharma manufacturers to quickly scale up vaccines, viral vector-based therapies, and other novel modalities.

To do so, GE Healthcare Life Sciences will work closely with Pharmadule Morimatsu, a company specializing in the design and manufacture of modular facilities. Pharmadule will provide engineering design, construction, installation, and validation services, based on GE Healthcare Life Sciences' proprietary design.

Read more at

https://www.gelifesciences.com/en/us/news-center/ge-healthcare-life-sciences-and-pharmadule-morimatsu-collaborate-10001


 

 

Back to news
Pharmadule Morimatsu AB  |   DanvikCenter 28  |   SE - 131 30 Nacka  Sweden  |   Phone: +46 (0)8 587 42 000  |   Email: info@pharmadule.com